PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.\', \'Division of Angiology and Haemostasis, University Hospitals of Geneva, Geneva, Switzerland.\', \'Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.\', \'Department of Hematology-Hemostasis, University Hospital of Tours, Tours, France.\', \'Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald, Greifswald, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/jth.15262
?:hasPublicationType
?:journal
  • Journal of thrombosis and haemostasis : JTH
is ?:pmid of
?:pmid
?:pmid
  • 33550713
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all